13F
← All fund report cards

Nippon Life Global Investors Americas, Inc.

13F equity value
$2.2B
Positions
106
Top 10 concentration
47.1%
Quarters / total new picks
32 / 381
13F equity value over time
$0M$1B$2B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +1.7% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 56.2% of quarters (excess t = 0.26, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+0.4%
t-stat
0.26
Quarterly win rate
56%
Annualized excess
-3.7%
$1 → follow vs universe
$1.59 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.06620180630: follow 1.03420180930: follow 1.03620181231: follow 1.08920190331: follow 1.13220190630: follow 1.28520190930: follow 1.38220191231: follow 1.19020200331: follow 1.38020200630: follow 1.54520200930: follow 1.68220201231: follow 1.68120210331: follow 1.77420210630: follow 1.72020210930: follow 1.57020211231: follow 1.36220220331: follow 1.45220220630: follow 1.44020220930: follow 1.56420221231: follow 1.51920230331: follow 1.61620230630: follow 1.61520230930: follow 1.69920231231: follow 1.75520240331: follow 1.78720240630: follow 1.73520240930: follow 1.66520241231: follow 1.56220250331: follow 1.74520250630: follow 1.60520250930: follow 1.75620251231: follow 1.586 0.84 1.54 2.25 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 106 · 2026 Q1

Ticker Value Weight QoQ
NVDA $196M
8.8%
TRIM
GOOG $138M
6.2%
ADD
MSFT $128M
5.8%
TRIM
AAPL $115M
5.2%
ADD
AMZN $109M
4.9%
TRIM
AVGO $92M
4.2%
TRIM
META $74M
3.3%
ADD
LLY $70M
3.1%
HOLD
COST $62M
2.8%
TRIM
LRCX $60M
2.7%
ADD
C $58M
2.6%
TRIM
GE $49M
2.2%
NEW
APH $45M
2.0%
TRIM
GS $43M
1.9%
TRIM
MDT $43M
1.9%
HOLD
PG $42M
1.9%
ADD
AON $42M
1.9%
ADD
CAT $40M
1.8%
TRIM
V $37M
1.7%
ADD
BA $37M
1.7%
ADD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.